Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor
about
Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles.Review: Immunology of sinusitis, trauma, asthma, and sepsis.Plasma thioredoxin levels during post-cardiac arrest syndrome: relationship with severity and outcome.A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels.Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentalsSynthesis and activity of thioether-containing analogues of the complement inhibitor compstatin.Plasma and Synovial Fluid TrxR Levels are Correlated With Disease Risk and Severity in Patients With Rheumatoid Arthritis.The thiol pool in human plasma: the central contribution of albumin to redox processes.Cell stress proteins in atherothrombosisNeuroprotective Activity of Grape Seed and Skin Extract Against Lithium Exposure Using Proteomic Research.Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study.A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.
P2860
Q30639688-D5329D62-0DEB-4A61-AFEA-042FC1CF7010Q33564143-E892E804-68B3-4064-AE08-F9BBD83A86AAQ33752742-5385D30B-AE95-4A4A-8823-D248EBE764FCQ34001569-BA12625F-48B1-4616-8649-E128F5D866D6Q34089741-87D4A13E-D190-41FF-B31A-531E66AC01C5Q34534501-F5B2C35A-0A8A-49AE-8A92-411D36E29AD4Q35109329-BDA2346C-09B5-4BE4-8A0F-7B9BD0CDF830Q36580833-929461A2-A34B-4279-AC8E-C0C081B6F12AQ37540768-74035D2B-E4E8-45CB-B44E-4ABDDB26193FQ38026043-8FC786BB-5630-4A13-B579-AAD98415F4C1Q38891987-79541CB4-7683-4DFA-B9C8-FB608695294CQ41415236-C6DC6EE5-EF68-4499-9ACC-8131E1EABB07Q50553669-95A576FA-DBBB-473B-99F6-EF484A131258
P2860
Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@ast
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@en
type
label
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@ast
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@en
prefLabel
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@ast
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@en
P2093
P2860
P921
P1476
Increased plasma thioredoxin l ...... ge migration inhibitory factor
@en
P2093
Anne Burke-Gaffney
Matthew B Hacking
Susannah K Leaver
Timothy W Evans
Vasisht Pingle
P2860
P2888
P304
P356
10.1007/S00134-009-1640-Z
P577
2009-09-15T00:00:00Z